Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

Autor: Moreau, Philippe, Pylypenko, Halyna, Grosicki, Sebastian, Karamanesht, Ievgenii, Leleu, Xavier, Grishunina, Maria, Rekhtman, Grigoriy, Masliak, Zvenyslava, Robak, Tadeusz, Shubina, Anna, Arnulf, Bertrand, Kropff, Martin, Cavet, James, Esseltine, Dixie-Lee, Feng, Huaibao, Girgis, Suzette, van de Velde, Helgi, Deraedt, William, Harousseau, Jean-Luc
Zdroj: In Lancet Oncology 2011 12(5):431-440
Databáze: ScienceDirect